Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2008
09/12/2008WO2008109377A1 Nucleic acid compounds for inhibiting vegf family gene expression and uses thereof
09/12/2008WO2008109376A1 Nucleic acid compounds for inhibiting bcr-abl gene expression and uses thereof
09/12/2008WO2008109375A2 Nucleic acid compounds for inhibiting pik3c gene expression and uses thereof
09/12/2008WO2008109374A1 Nucleic acid compounds for inhibiting mapk gene expression and uses thereof
09/12/2008WO2008109373A1 Nucleic acid compounds for inhibiting erbb gene expression and uses thereof
09/12/2008WO2008109372A2 Nucleic acid compounds for inhibiting pdgf gene expression and uses thereof
09/12/2008WO2008109371A1 Nucleic acid compounds for inhibiting p38 mapk family gene expression and uses thereof
09/12/2008WO2008109370A2 Nucleic acid compounds for inhibiting srd5a1 gene expression and uses thereof
09/12/2008WO2008109369A2 Nucleic acid compounds for inhibiting tnf gene expression and uses thereof
09/12/2008WO2008109368A2 Nucleic acid compounds for inhibiting vegfr gene expression and uses thereof
09/12/2008WO2008109366A2 Nucleic acid compounds for inhibiting ccnd1 gene expression and uses thereof
09/12/2008WO2008109365A1 Nucleic acid compounds for inhibiting raf1 gene expression and uses thereof
09/12/2008WO2008109364A2 Nucleic acid compounds for inhibiting frap1 gene expression and uses thereof
09/12/2008WO2008109362A1 Nucleic acid compounds for inhibiting vegf gene expression and uses thereof
09/12/2008WO2008109361A1 Nucleic acid compounds for inhibiting erbb family gene expression and uses thereof
09/12/2008WO2008109359A1 Nucleic acid compounds for inhibiting pdgfr family gene expression and uses thereof
09/12/2008WO2008109358A1 Nucleic acid compounds for inhibiting mapk1 gene expression and uses thereof
09/12/2008WO2008109357A1 Nucleic acid compounds for inhibiting apob gene expression and uses thereof
09/12/2008WO2008109356A1 Nucleic acid compounds for inhibiting tnfsf13b gene expression and uses thereof
09/12/2008WO2008109355A1 Nucleic acid compounds for inhibiting srd5a2 gene expression and uses thereof
09/12/2008WO2008109354A1 Nucleic acid compounds for inhibiting il18 gene expression and uses thereof
09/12/2008WO2008109353A1 Nucleic acid compounds for inhibiting map2k gene expression and uses thereof
09/12/2008WO2008109352A2 Nucleic acid compounds for inhibiting akt gene expression and uses thereof
09/12/2008WO2008109350A2 Nucleic acid compounds for inhibiting il6 gene expression and uses thereof
09/12/2008WO2008109274A1 Nell-1 enhanced bone mineralization
09/12/2008WO2008109142A2 Pirna and uses related thereto
09/12/2008WO2008109105A2 Methods and compositions for improved therapeutic effects with sirna
09/12/2008WO2008108890A2 Conditionally replicating viruses for cancer therapy
09/12/2008WO2008108877A2 Specific lysis of staphylococcal pathogens by bacteriophage phi1 1 endolysin
09/12/2008WO2008108668A1 Transferases, epimerases, polynucleotides encoding these and uses thereof
09/12/2008WO2008108660A2 Fish disease detection
09/12/2008WO2008108640A1 A gene mutated in fanconi anemia complementation group i
09/12/2008WO2008108470A1 Method of evaluating foam-holding properties of fermented malt drink and marker for evaluating foam-holding properties
09/12/2008WO2008108466A1 Improved halohydrin epoxidase
09/12/2008WO2008108385A1 Method for measurement of glycosylated hexapeptide
09/12/2008WO2008108345A1 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein
09/12/2008WO2008108344A1 Cell for gene therapy of lcat deficiency, and replication-deficient retrovirus vector and plasmid for use in the production of the cell
09/12/2008WO2008108325A1 Novel beta-galactoside-alpha-2,6-sialyltransferase, gene encoding the same and method for enhancing enzymatic activity
09/12/2008WO2008108257A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
09/12/2008WO2008108116A1 Cellulase enzyme and method of producing the same
09/12/2008WO2008108103A1 Composition for cleaving and/or connecting single strand dna
09/12/2008WO2008108004A1 Chip for sampling cell component, system for analyzing cell component and method of analyzing cell component using the same
09/12/2008WO2008107901A2 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial
09/12/2008WO2008107782A2 Modified hydroxylase and its applications
09/12/2008WO2008107725A1 A method for the construction of cancer-specific promoters using functional genomics
09/12/2008WO2008107509A1 Method for modifying the inflorescence architecture of plants
09/12/2008WO2008107508A1 Use of snail1 activity inhibiting compounds in the preparation of pharmaceutical compositions intended for the treatment of chondrodystrophies, method for identifying inhibiting compounds, pharmaceutical compositions, chondrodystrophy diagnosis method and applications thereof
09/12/2008WO2008107489A1 Aptamer-based reagents for a target molecule involved in hemostasis
09/12/2008WO2008107462A2 Plasmid containing a sequence encoding a disintegrin domain of metargidin (rdd)
09/12/2008WO2008107422A1 Osteopontin for the prediction and treatment of cardiovascular diseases
09/12/2008WO2008107388A1 Improvement of protein production
09/12/2008WO2008107370A1 Novel method and compositions
09/12/2008WO2008107277A1 Method for the production of l-amino acids using strains of the enterobacteriaceae family
09/12/2008WO2008106986A1 Pig model for psoriasis
09/12/2008WO2008106985A1 Pig model
09/12/2008WO2008106984A2 Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex
09/12/2008WO2008106982A2 Pig model for atherosclerosis
09/12/2008WO2008106981A1 Transgenic pig as a model of alzheimer's disease
09/12/2008WO2008106896A1 Transgenic rodents having ngf beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins
09/12/2008WO2008106803A1 Double-stranded locked nucleic acid compositions
09/12/2008WO2008106796A1 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity
09/12/2008WO2008106785A1 Assessment of risk for colorectal cancer
09/12/2008WO2008106782A1 Serial siphon valves for fluidic or microfluidic devices
09/12/2008WO2008106739A1 Vectors and methods for enzyme production
09/12/2008WO2008106701A2 Dna segregation
09/12/2008WO2008089569A9 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens
09/12/2008WO2008085956A3 High expression cell line that eliminates gene amplification
09/12/2008WO2008080413A3 An antisense oligonucleotide, pharmaceutical composition and a method for downregulation of peripheral neuronal nitric oxide synthase and mu-opioid receptors and use of an antisense oligonucleotide for drug production
09/12/2008WO2008080045A3 Dr6 antibodies inhibiting the binding of dr6 to app, and uses thereof in treating neurological disorders
09/12/2008WO2008076831A3 Generation of plants with altered oil, protein, or fiber content
09/12/2008WO2008069942A3 Novel methods of enhancing delivery of a gene therapy vector using steroids
09/12/2008WO2008061159A3 Generation of plants with altered protein, fiber, or oil, content
09/12/2008WO2008056376A3 A recombinant meso-active thermo-stable protein and the process of design and biosynthesis thereof
09/12/2008WO2008054881A9 Antibacterial and plasmid elimination agents
09/12/2008WO2008045804A3 Ph sensitive liposome composition
09/12/2008WO2008039357A3 Uncoupling of dna insert propagation and expression of protein for phage display
09/12/2008WO2007081631A3 Method of producing insulin-secreting cells from adult stem cells via transfection
09/12/2008WO2007059298B1 Chimeric immunoreceptor useful in treating human cancers
09/12/2008WO2007028165A3 Stress tolerance in plants
09/12/2008WO2006091895A3 Method for the treatment of retinopathy of prematurity and related retinopathic diseases
09/12/2008CA2717251A1 Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex
09/12/2008CA2717239A1 Transgenic pig as a model of alzheimer's disease
09/12/2008CA2716990A1 Pig model for atherosclerosis
09/12/2008CA2715856A1 Pig model for psoriasis
09/12/2008CA2715852A1 A pig whose genome comprises a site-specific, heterologous recombination site
09/12/2008CA2680202A1 Pirna and uses related thereto
09/12/2008CA2680196A1 Transferases, epimerases, polynucleotides encoding these and uses thereof
09/12/2008CA2680168A1 Determining foam-holding properties of a fermented malt drink based on protein z7
09/12/2008CA2680129A1 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell
09/12/2008CA2680114A1 Plasmid containing a sequence encoding a disintegrin domain of metargidin (rdd)
09/12/2008CA2680060A1 Double-stranded locked nucleic acid compositions
09/12/2008CA2680058A1 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity
09/12/2008CA2679954A1 Assessment of risk for colorectal cancer
09/12/2008CA2679926A1 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein
09/12/2008CA2679867A1 Nucleic acid compounds for inhibiting vegf family gene expression and uses thereof
09/12/2008CA2679841A1 Variant activin receptor polypeptides and uses thereof
09/12/2008CA2679757A1 Nucleic acid compounds for inhibiting erbb family gene expression and uses thereof
09/12/2008CA2679743A1 Methods and compositions involving polymeric immunoglobulin fusion proteins
09/12/2008CA2679723A1 Nell-1 enhanced bone mineralization
09/12/2008CA2679703A1 A novel .beta.-galactoside-.alpha.2,6-sialyltransferase, a gene encoding thereof, and a method for enhancing enzyme activity
1 ... 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 ... 4023